Max Rady College of Medicine

Term: Therapeutic Interchange Policy

Printer friendly

Glossary Definition

Last Updated: 2005-12-05

Definition:

Reimbursing consumers at the rate of the lowest price equivalent drug - a policy that promotes consumer's price sensitivity when selecting among both patented and non-patented products. Uses reference based pricing mechanisms, prescribing protocols, and special authority restrictions to regulate the use of higher priced chemically distinct but therapeutically similar products.

Related terms 

References 

  • Morgan SG, Kozyrskyj A, Metge C, Roos NP. Pharmaceuticals: Therapeutic interchange and pricing policies. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary] (View)


Request information in an accessible format

If you require access to our resources in a different format, please contact us:

We strive to provide accommodations upon request in a reasonable timeframe.

Contact us

Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada

204-789-3819